Werewolf Therapeutics Reports 2025 Results

Werewolf Therapeutics has disclosed its financial results for the fourth quarter and the full year of 2025, alongside recent corporate updates. The company is actively exploring strategic options aimed at maximizing shareholder value. This suggests a period of significant evaluation and potential transformation for the biotechnology firm. Investors will be keen to understand the details of these strategic reviews and their potential impact on the company's future trajectory and market position.